Advocacy intelligence hub — real-time data for patient organizations
Northwestern University — EARLY_PHASE1
Daiichi Sankyo — PHASE1
Michael Wagner, MD — PHASE1
M.D. Anderson Cancer Center — PHASE1
Valo Therapeutics Oy — PHASE1
USWM CT, LLC — PHASE2
USWM CT, LLC — PHASE2
Data from FDA regulatory filings and ClinicalTrials.gov. Updated periodically.
FINANCIAL LANDSCAPE SUMMARY
Total programs
Neeta Somaiah, M.D
M.D. Anderson Cancer Center
📍 HOUSTON, TX
Michael Pishvaian, MD
Georgetown University
📍 WASHINGTON, DC
Mark Agulnik, MD
City of Hope
📍 LOS ANGELES, CA
William D Tap, MD
Memorial Sloan Kettering Cancer Center
📍 NEW YORK, NY
Brian A Van Tine
Washington University School of Medicine
Edward Stadtmauer, MD
University of Pennsylvania
📍 PHILADELPHIA, PA